We are live on ! Find out more
NEOS

Neos Therapeutics, Inc
NEOS

Delisted

NEOS was delisted on the 19th of March, 2021.

Back to rankings

44 hedge funds and large institutions have $12.2M invested in Neos Therapeutics, Inc in 2020 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 12 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

10% less funds holding

Funds holding: 49 → 44 (-5)

16% less capital invested

Capital invested by funds: $14.6M → $12.2M (-$2.39M)

42% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 12

67% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 6

Holders
44
Holders Change
-5
Holders Change %
-10.2%
% of All Funds
0.9%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
2
Increased
7
Reduced
12
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$197K
2
BCM
Bridgeway Capital Management
Texas
+$142K
3
Renaissance Technologies
Renaissance Technologies
New York
+$96.6K
4
Goldman Sachs
Goldman Sachs
New York
+$43.7K
5
Squarepoint
Squarepoint
New York
+$16.5K

Top Sellers

Rank Fund Capital Flow
1
SFM
Sphera Funds Management
Israel
-$1.24M
2
SCM
Stonepine Capital Management
Oregon
-$193K
3
BlackRock
BlackRock
New York
-$101K
4
Wells Fargo
Wells Fargo
California
-$51.7K
5
Millennium Management
Millennium Management
New York
-$28.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
26
Wells Fargo
California
$13K -$51.7K -65,240 -78%
Millennium Management
27
Millennium Management
New York
$11K -$28.6K -36,016 -69%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$9K – – –
Commonwealth Equity Services
29
Commonwealth Equity Services
Massachusetts
$9K – – –
AG
30
Algert Global
California
$8K -$9.29K -11,720 -51%
Bank of America
31
Bank of America
North Carolina
$7K – – –
RJA
32
Raymond James & Associates
Florida
$7K – – –
SCA
33
Stonebridge Capital Advisors
Minnesota
$5K -$2.38K -3,000 -30%
Royal Bank of Canada
34
Royal Bank of Canada
Ontario, Canada
$3K – – –
Citigroup
35
Citigroup
New York
$1K – – –
TFGT
36
TS Financial Group (TSFG)
Illinois
$1K – – –
BNP Paribas Financial Markets
37
BNP Paribas Financial Markets
France
$178 – – –
Citadel Advisors
38
Citadel Advisors
Florida
– -$26K -34,271 Closed
WG
39
Winton Group
United Kingdom
– -$22K -29,418 Closed
AIM
40
Alambic Investment Management
California
– -$19K -24,689 Closed
Victory Capital Management
41
Victory Capital Management
Texas
– -$12K -16,368 Closed
Susquehanna International Group
42
Susquehanna International Group
Pennsylvania
– -$12K -15,359 Closed
CIBC Private Wealth Group
43
CIBC Private Wealth Group
Georgia
– -$12K -15,335 Closed
Osaic Holdings
44
Osaic Holdings
Arizona
– -$3.16K -3,990 -91%
JP Morgan Chase
45
JP Morgan Chase
New York
– +$11 +14 New
1
2

NEOS Hedge Fund Activity: Q2 2020 in Review

44 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Neos Therapeutics, Inc (NEOS) for Q2 2020, worth a combined $12.2M — down 16% from $14.6M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of NEOS and 2 opened new positions — a net loss of 4 holders — while 12 trimmed existing stakes and 7 added.

The largest buyer was Jacobs Levy Equity Management, adding an estimated $197K. The largest seller was Sphera Funds Management, cutting an estimated $1.24M.

  • 44 institutional investors held Neos Therapeutics, Inc (NEOS) as of Q2 2020, down from 49 in Q1 2020.
  • Funds reported $12.2M of Neos Therapeutics, Inc stock for Q2 2020, down 16% quarter-over-quarter.
  • 2 funds opened new Neos Therapeutics, Inc positions in Q2 2020 and 6 closed out, a net change of -4 holders.
  • The largest Neos Therapeutics, Inc buyer in Q2 2020 was Jacobs Levy Equity Management, an estimated $197K added.
  • The largest Neos Therapeutics, Inc seller in Q2 2020 was Sphera Funds Management, an estimated $1.24M sold.

Based on aggregated 13F filings for Q2 2020.